Abbott's investigational device achieved 96.3% complete left atrial appendage closure by echocardiography, with a 1.8% ischemic stroke rate at 1 year.
News|Podcasts|March 29, 2009
Podcast: Diagnosis and Treatment of Patients With Postconcussion Syndrome
Randolph W. Evans, MD, chief of neurology at Park Plaza Hospital and clinical professor at Baylor College of Medicine in Houston, Texas, reviews postconcussion syndrome and post-traumatic headache.
Advertisement
Randolph W. Evans, MD, chief of neurology at Park Plaza Hospital and clinical professor at Baylor College of Medicine in Houston, Texas, reviews postconcussion syndrome and post-traumatic headache.
Evans Podcast
Advertisement
Related to this article
Hormone Therapy Linked to More Frequent Migraines, but Not Greater Severity, in Postmenopausal Women
TMS 2026: A meta-analysis of 5 studies found hormone therapy linked to more frequent migraine attacks and migraine days, but not greater severity or analgesic use.
FDA has granted IDE approval for the STROKE-REWIRE pivotal trial evaluating NeuWire Medical's neurostimulation device for chronic ischemic stroke recovery.
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
Stroke incidence in adults aged 20–54 nearly doubled from 1993–1994 to 2020, driven largely by ischemic stroke, while 30-day fatality declined, according to new research.
Advertisement
Advertisement
Trending on Patient Care Online
1
When Night Sweats Signal Something Other Than Menopause
2
Abbott's Amulet 360 Linked to Low Stroke Risk at 1 Year in Late-Breaking Research
3
4 FDA Decisions for Primary Care to Know from October 2026
4
New Schizophrenia Treatment Addresses Long-Standing LAI Barriers
5